Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | G protein-coupled receptor kinase 1 | 0.1928 | 0.8892 | 0.8892 |
Loa Loa (eye worm) | AGC/GRK/BARK protein kinase | 0.0219 | 0.0027 | 0.0027 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0214 | 0 | 0.5 |
Brugia malayi | Probable G protein-coupled receptor kinase F19C6.1, putative | 0.1928 | 0.8892 | 0.8892 |
Entamoeba histolytica | hypothetical protein | 0.0214 | 0 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0214 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0214 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0214 | 0 | 0.5 |
Echinococcus granulosus | beta-adrenergic receptor kinase | 0.0219 | 0.0027 | 0.003 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0214 | 0 | 0.5 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0219 | 0.0027 | 0.0027 |
Echinococcus multilocularis | beta adrenergic receptor kinase | 0.0219 | 0.0027 | 0.003 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0214 | 0 | 0.5 |
Schistosoma mansoni | serine/threonine protein kinase | 0.2141 | 1 | 1 |
Echinococcus multilocularis | G protein coupled receptor kinase 6 | 0.1928 | 0.8892 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0214 | 0 | 0.5 |
Echinococcus granulosus | [G-protein-coupledreceptor] kinase | 0.1928 | 0.8892 | 1 |
Trichomonas vaginalis | regulator of G protein signaling 5, rgs5, putative | 0.0214 | 0 | 0.5 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0219 | 0.0027 | 0.0027 |
Loa Loa (eye worm) | AGC/GRK/GRK protein kinase | 0.2141 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0214 | 0 | 0.5 |
Loa Loa (eye worm) | AGC/GRK/GRK protein kinase | 0.1928 | 0.8892 | 0.8892 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (binding) | = 58 % | Inhibition of recombinant human BACE1 at 2 uM by FRET analysis | ChEMBL. | 23993670 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.